Comparative diagnostic accuracy of PSMA-PET versus conventional imaging for Initial T/N/M staging of intermediate- to high-risk prostate cancer: a patient-level paired bivariate meta-analysis.
- 1Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
- 2Department of Urology, West China Hospital, Sichuan University, Chengdu, China. [email protected].
Abstract
Purpose
To compare the patient-level diagnostic accuracy of PSMA-PET with multiparametric magnetic resonance imaging (mpMRI), computed tomography (CT), and bone scintigraphy (BS) for initial T, N, and M staging of newly diagnosed intermediate- to high-risk prostate cancer using paired studies.Methods
We searched PubMed, Embase, Web of Science, and Scopus from inception to December 1, 2025, for paired studies in which the same patients underwent PSMA-PET and conventional imaging, with histopathology or predefined composite criteria as the reference standard. Risk of bias was assessed with QUADAS-2 and QUADAS-C. Pooled sensitivity and specificity with 95% confidence intervals (CIs) were estimated using bivariate composite-likelihood models. Modality effects were tested by meta-regression and likelihood ratio tests, and absolute between-modality differences with 95% CIs were estimated using the delta method.Results
Forty-three studies including 4,023 patients were analyzed. For local T staging, PSMA-PET did not show uniform superiority over mpMRI. For extraprostatic extension, PSMA-PET/CT did not differ significantly from mpMRI in sensitivity (absolute difference, -7.6 percentage points; 95% CI, -16.1 to 0.9; p = 0.08) or specificity (-7.0 percentage points; 95% CI, -14.7 to 0.8; p = 0.08); no significant differences were observed for seminal vesicle invasion. In an exploratory six-study comparison, PSMA-PET/MRI had higher sensitivity than mpMRI for extraprostatic extension (+ 12.1 percentage points; 95% CI, 1.9 to 22.2; p = 0.02). For regional lymph node staging, PSMA-PET/CT sensitivity was 69.3% (95% CI, 56.6-79.7) versus 45.3% (95% CI, 33.0-58.3) for mpMRI (difference, + 24.1 percentage points; 95% CI, 6.0-40.3; p = 0.009), whereas specificity did not differ (difference, + 3.2 percentage points; 95% CI, -4.6 to 11.8; p = 0.41). For bone metastasis staging, PSMA-PET had greater sensitivity than BS (95.8% [95% CI, 92.8-98.7] versus 76.2% [95% CI, 68.7-83.8]) and greater specificity (92.8% [95% CI, 89.9-95.7] versus 77.4% [95% CI, 71.3-83.5]; both p < 0.001).Conclusions
PSMA-PET/CT was more sensitive than mpMRI for regional lymph node staging, while specificity was comparable. PSMA-PET had greater sensitivity and specificity than bone scintigraphy for bone metastasis staging. For local T staging, PSMA-PET did not show uniform superiority over mpMRI.
Related
- AI-Based MRI Radiomics for Preoperative Detection of Tumor Deposits in Rectal Cancer: A Bivariate Diagnostic Accuracy Meta-analysis
- Dermatophytes in Argentina: species distribution, comparative identification accuracy of conventional and proteomic methods, introduction of a novel molecular identification approach, and antifungal susceptibility profiles
- Diagnostic accuracy of a systematic approach using Swedescore versus conventional colposcopy for the detection of cervical intraepithelial neoplasia grade 2 or worse: A multicenter, non‐randomized clinical study
- Prospective Case Series to Determine the Feasibility, Diagnostic Yield and Safety of Performing EBUS Guided Trans‐Bronchial Mediastinal Cryobiopsy (EBUS‐TBMC) of Lymph Nodes Using 1.1 mm Cryoprobe Through a Working Channel of Linear EBUS Bronchoscope Versus Conventional En‐Bloc Cryobiopsy
- Evaluation of Tooth Shade Selection With Conventional Methods and Artificial Intelligence-Integrated Methods: A Comparative Study
BibTeX
@article{wu2026comparative,
title = {{Comparative diagnostic accuracy of PSMA-PET versus conventional imaging for Initial T/N/M staging of intermediate- to high-risk prostate cancer: a patient-level paired bivariate meta-analysis.}},
author = {Haowen Wu and Wei Zhang and Luchen Yang and Xin Yan and Pan Song and Qiang Dong},
journal = {BMC cancer},
year = {2026},
month = jul,
doi = {10.1186/s12885-026-16639-2},
url = {https://europepmc.org/article/MED/42928137},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Comparative diagnostic accuracy of PSMA-PET versus conventional imaging for Initial T/N/M staging of intermediate- to high-risk prostate cancer: a patient-level paired bivariate meta-analysis.
AU - Haowen Wu
AU - Wei Zhang
AU - Luchen Yang
AU - Xin Yan
AU - Pan Song
AU - Qiang Dong
PY - 2026
DA - 2026/07/28
JO - BMC cancer
DO - 10.1186/s12885-026-16639-2
UR - https://europepmc.org/article/MED/42928137
AB - Purpose To compare the patient-level diagnostic accuracy of PSMA-PET with multiparametric magnetic resonance imaging (mpMRI), computed tomography (CT), and bone scintigraphy (BS) for initial T, N, and M staging of newly diagnosed intermediate- to high-risk prostate cancer using paired studies.Methods We searched PubMed, Embase, Web of Science, and Scopus from inception to December 1, 2025, for paired studies in which the same patients underwent PSMA-PET and conventional imaging, with histopathology or predefined composite criteria as the reference standard. Risk of bias was assessed with QUADAS-2 and QUADAS-C. Pooled sensitivity and specificity with 95% confidence intervals (CIs) were estimated using bivariate composite-likelihood models. Modality effects were tested by meta-regression and likelihood ratio tests, and absolute between-modality differences with 95% CIs were estimated using the delta method.Results Forty-three studies including 4,023 patients were analyzed. For local T staging, PSMA-PET did not show uniform superiority over mpMRI. For extraprostatic extension, PSMA-PET/CT did not differ significantly from mpMRI in sensitivity (absolute difference, -7.6 percentage points; 95% CI, -16.1 to 0.9; p = 0.08) or specificity (-7.0 percentage points; 95% CI, -14.7 to 0.8; p = 0.08); no significant differences were observed for seminal vesicle invasion. In an exploratory six-study comparison, PSMA-PET/MRI had higher sensitivity than mpMRI for extraprostatic extension (+ 12.1 percentage points; 95% CI, 1.9 to 22.2; p = 0.02). For regional lymph node staging, PSMA-PET/CT sensitivity was 69.3% (95% CI, 56.6-79.7) versus 45.3% (95% CI, 33.0-58.3) for mpMRI (difference, + 24.1 percentage points; 95% CI, 6.0-40.3; p = 0.009), whereas specificity did not differ (difference, + 3.2 percentage points; 95% CI, -4.6 to 11.8; p = 0.41). For bone metastasis staging, PSMA-PET had greater sensitivity than BS (95.8% [95% CI, 92.8-98.7] versus 76.2% [95% CI, 68.7-83.8]) and greater specificity (92.8% [95% CI, 89.9-95.7] versus 77.4% [95% CI, 71.3-83.5]; both p < 0.001).Conclusions PSMA-PET/CT was more sensitive than mpMRI for regional lymph node staging, while specificity was comparable. PSMA-PET had greater sensitivity and specificity than bone scintigraphy for bone metastasis staging. For local T staging, PSMA-PET did not show uniform superiority over mpMRI.
SN - 1471-2407
ER -